- Home
- OPRA vs TNGX Comparison
OPRA vs TNGX Comparison
Compare OPRA & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPRA
- TNGX
- Stock Information
- Founded
- OPRA 1996
- TNGX 2014
- Country
- OPRA Norway
- TNGX United States
- Employees
- OPRA N/A
- TNGX N/A
- Industry
- OPRA Computer Software: Prepackaged Software
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- OPRA Technology
- TNGX Health Care
- Exchange
- OPRA Nasdaq
- TNGX Nasdaq
- Market Cap
- OPRA 1.2B
- TNGX 1.0B
- IPO Year
- OPRA 2018
- TNGX N/A
- Fundamental
- Price
- OPRA $13.47
- TNGX $8.18
- Analyst Decision
- OPRA Strong Buy
- TNGX Strong Buy
- Analyst Count
- OPRA 3
- TNGX 6
- Target Price
- OPRA $23.83
- TNGX $10.80
- AVG Volume (30 Days)
- OPRA 987.2K
- TNGX 4.5M
- Earning Date
- OPRA 10-29-2025
- TNGX 11-04-2025
- Dividend Yield
- OPRA 5.94%
- TNGX N/A
- EPS Growth
- OPRA N/A
- TNGX N/A
- EPS
- OPRA 0.90
- TNGX N/A
- Revenue
- OPRA $583,449,000.00
- TNGX $66,501,000.00
- Revenue This Year
- OPRA $27.64
- TNGX $20.41
- Revenue Next Year
- OPRA $15.07
- TNGX N/A
- P/E Ratio
- OPRA $14.98
- TNGX N/A
- Revenue Growth
- OPRA 30.29
- TNGX 53.29
- 52 Week Low
- OPRA $12.83
- TNGX $1.03
- 52 Week High
- OPRA $22.50
- TNGX $9.70
- Technical
- Relative Strength Index (RSI)
- OPRA 32.35
- TNGX 52.85
- Support Level
- OPRA $13.57
- TNGX $7.49
- Resistance Level
- OPRA $14.31
- TNGX $8.74
- Average True Range (ATR)
- OPRA 0.65
- TNGX 0.64
- MACD
- OPRA -0.02
- TNGX -0.03
- Stochastic Oscillator
- OPRA 11.05
- TNGX 59.49
About OPRA Opera Limited
Opera Ltd is a world-wide internet brand with a large, engaged, and growing base. It offers users products and services that include a variety of PC and mobile browsers, Opera Gaming portals and development tools, Opera News content recommendation products, and a number of e-commerce products and services. Its browser's features include tabbed browsing, data savings, PC/mobile sync, and numerous features focused on privacy and security, including ad blocking and a built-in VPN. Its browser products include Opera Mini, Opera Browser for Android and iOS, Opera for Computers, Opera GX and Opera GX Mobile, separate browsers tailored for gamers. Geographically, the company generates maximum revenue from the United States, followed by Singapore, Nigeria, Russia, and other locations.
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.